ORASURE TECHNOLOGIES, INC Other Non-Current Liabilities
ORASURE TECHNOLOGIES, INC (OSUR) had Other Non-Current Liabilities of $2.48 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Noncurrent $2.48M.
- 2026-03-31: Other Liabilities, Noncurrent $2.29M.
- 2025-12-31: Other Liabilities, Noncurrent $2.24M.
- 2025-09-30: Other Liabilities, Noncurrent $2.25M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $2.29M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $2.24M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.25M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.85M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $445.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $494.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $529.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $523.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $727.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $696.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $595.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $586.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $609.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $581.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $525.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $489.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $552.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $651.00K 10-K · filed 2023-03-03 |
| 2021-09-30 | $2.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.01M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.68M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.49M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.51M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.64M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.85M 10-K · filed 2021-03-01 |
| 2019-09-30 | $3.58M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $3.54M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.47M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.31M 10-K · filed 2020-03-02 |
| 2018-09-30 | $4.65M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $4.47M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $4.26M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $3.93M 10-K · filed 2019-02-28 |
| 2017-09-30 | $3.93M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.54M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.16M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.30M 10-K · filed 2018-02-28 |
| 2016-09-30 | $2.29M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $2.02M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $2.07M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.77M 10-K · filed 2017-03-14 |
| 2015-09-30 | $1.14M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $1.26M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.31M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.23M 10-K · filed 2016-03-14 |
| 2014-09-30 | $1.09M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $1.16M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $961.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $677.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $539.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $383.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $249.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $89.00K 10-K · filed 2014-03-14 |
| 2012-09-30 | $67.36K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $29.87K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $8.40K 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |